Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy

Journal of Dermatological Case Reports

Natalia Zdanowska¹  Aleksandra Znajewska-Pander¹  Waldemar Placek¹  Agnieszka Owczarczyk-Saczonek¹ 

[1]Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland.

关键词: adalimumab;    adverse reactions;    golimumab;    infliximab;    tumor necrosis factor;   

DOI  :  10.3315/jdcr.2016.1224

学科分类：皮肤病学

来源: Specjalisci Dermatolodz

【 摘 要 】

Etanercept and other anti-TNF-alpha agents have been indicated as a therapeutic option in severe drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Etanercept has been shown to quickly reduce the detachment of the epidermis and shorten healing time. Cases of etanercept-induced severe adverse drug reactions were also described.

【 授权许可】

Unknown